Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study.
Identifieur interne : 001425 ( Ncbi/Curation ); précédent : 001424; suivant : 001426Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study.
Auteurs : A. Geloen [Australie] ; K. Chapelier ; A. Cividjian ; E. Dantony ; M. Rabilloud ; C N May ; L. QuintinSource :
- Critical care medicine [ 1530-0293 ] ; 2013.
Descripteurs français
- KwdFr :
- Agonistes des récepteurs alpha-2 adrénergiques (usage thérapeutique), Animaux, Attribution aléatoire, Choc septique (), Choc septique (physiopathologie), Clonidine (usage thérapeutique), Dexmédétomidine (usage thérapeutique), Hypotension artérielle (physiopathologie), Hypotension artérielle (traitement médicamenteux), Hypotension artérielle (étiologie), Lipopolysaccharides, Mâle, Norépinéphrine (usage thérapeutique), Pression artérielle (), Projets pilotes, Rat Sprague-Dawley, Rats, Vasoconstricteurs (usage thérapeutique).
- MESH :
- physiopathologie : Choc septique, Hypotension artérielle.
- traitement médicamenteux : Hypotension artérielle.
- usage thérapeutique : Agonistes des récepteurs alpha-2 adrénergiques, Clonidine, Dexmédétomidine, Norépinéphrine, Vasoconstricteurs.
- étiologie : Hypotension artérielle.
- Animaux, Attribution aléatoire, Choc septique, Lipopolysaccharides, Mâle, Pression artérielle, Projets pilotes, Rat Sprague-Dawley, Rats.
English descriptors
- KwdEn :
- Adrenergic alpha-2 Receptor Agonists (therapeutic use), Animals, Arterial Pressure (drug effects), Clonidine (therapeutic use), Dexmedetomidine (therapeutic use), Hypotension (drug therapy), Hypotension (etiology), Hypotension (physiopathology), Lipopolysaccharides, Male, Norepinephrine (therapeutic use), Pilot Projects, Random Allocation, Rats, Rats, Sprague-Dawley, Shock, Septic (chemically induced), Shock, Septic (complications), Shock, Septic (physiopathology), Vasoconstrictor Agents (therapeutic use).
- MESH :
- chemical , therapeutic use : Adrenergic alpha-2 Receptor Agonists, Clonidine, Dexmedetomidine, Norepinephrine, Vasoconstrictor Agents.
- chemically induced : Shock, Septic.
- complications : Shock, Septic.
- drug effects : Arterial Pressure.
- drug therapy : Hypotension.
- etiology : Hypotension.
- physiopathology : Hypotension, Shock, Septic.
- Animals, Lipopolysaccharides, Male, Pilot Projects, Random Allocation, Rats, Rats, Sprague-Dawley.
Abstract
During septic shock, vasopressors are a cornerstone of therapy. In septic shock, very high doses of vasopressors sometimes have to be used due to vascular desensitization, the mechanisms of which are poorly understood. This study assesses whether α-2 agonists increase pressor responsiveness following lipopolysaccharide administration.
DOI: 10.1097/CCM.0b013e3182986248
PubMed: 23963131
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003A74
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003944
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003944
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001425
Links to Exploration step
pubmed:23963131Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study.</title><author><name sortKey="Geloen, A" sort="Geloen, A" uniqKey="Geloen A" first="A" last="Geloen">A. Geloen</name><affiliation wicri:level="3"><nlm:affiliation>1INSERM U1060 INSA-Lyon, University of Lyon, Lyon, France. 2Physiologie, University of Lyon, Lyon, France. 3Hospices Civils de Lyon, Service de Biostatistique, Lyon, France. 4Université Lyon I, Villeurbanne, France. 5CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Villeurbanne, France. 6Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>1INSERM U1060 INSA-Lyon, University of Lyon, Lyon, France. 2Physiologie, University of Lyon, Lyon, France. 3Hospices Civils de Lyon, Service de Biostatistique, Lyon, France. 4Université Lyon I, Villeurbanne, France. 5CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Villeurbanne, France. 6Florey Institute of Neuroscience and Mental Health, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Chapelier, K" sort="Chapelier, K" uniqKey="Chapelier K" first="K" last="Chapelier">K. Chapelier</name></author><author><name sortKey="Cividjian, A" sort="Cividjian, A" uniqKey="Cividjian A" first="A" last="Cividjian">A. Cividjian</name></author><author><name sortKey="Dantony, E" sort="Dantony, E" uniqKey="Dantony E" first="E" last="Dantony">E. Dantony</name></author><author><name sortKey="Rabilloud, M" sort="Rabilloud, M" uniqKey="Rabilloud M" first="M" last="Rabilloud">M. Rabilloud</name></author><author><name sortKey="May, C N" sort="May, C N" uniqKey="May C" first="C N" last="May">C N May</name></author><author><name sortKey="Quintin, L" sort="Quintin, L" uniqKey="Quintin L" first="L" last="Quintin">L. Quintin</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23963131</idno><idno type="pmid">23963131</idno><idno type="doi">10.1097/CCM.0b013e3182986248</idno><idno type="wicri:Area/PubMed/Corpus">003A74</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003A74</idno><idno type="wicri:Area/PubMed/Curation">003944</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003944</idno><idno type="wicri:Area/PubMed/Checkpoint">003944</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003944</idno><idno type="wicri:Area/Ncbi/Merge">001425</idno><idno type="wicri:Area/Ncbi/Curation">001425</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study.</title><author><name sortKey="Geloen, A" sort="Geloen, A" uniqKey="Geloen A" first="A" last="Geloen">A. Geloen</name><affiliation wicri:level="3"><nlm:affiliation>1INSERM U1060 INSA-Lyon, University of Lyon, Lyon, France. 2Physiologie, University of Lyon, Lyon, France. 3Hospices Civils de Lyon, Service de Biostatistique, Lyon, France. 4Université Lyon I, Villeurbanne, France. 5CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Villeurbanne, France. 6Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>1INSERM U1060 INSA-Lyon, University of Lyon, Lyon, France. 2Physiologie, University of Lyon, Lyon, France. 3Hospices Civils de Lyon, Service de Biostatistique, Lyon, France. 4Université Lyon I, Villeurbanne, France. 5CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Villeurbanne, France. 6Florey Institute of Neuroscience and Mental Health, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Chapelier, K" sort="Chapelier, K" uniqKey="Chapelier K" first="K" last="Chapelier">K. Chapelier</name></author><author><name sortKey="Cividjian, A" sort="Cividjian, A" uniqKey="Cividjian A" first="A" last="Cividjian">A. Cividjian</name></author><author><name sortKey="Dantony, E" sort="Dantony, E" uniqKey="Dantony E" first="E" last="Dantony">E. Dantony</name></author><author><name sortKey="Rabilloud, M" sort="Rabilloud, M" uniqKey="Rabilloud M" first="M" last="Rabilloud">M. Rabilloud</name></author><author><name sortKey="May, C N" sort="May, C N" uniqKey="May C" first="C N" last="May">C N May</name></author><author><name sortKey="Quintin, L" sort="Quintin, L" uniqKey="Quintin L" first="L" last="Quintin">L. Quintin</name></author></analytic><series><title level="j">Critical care medicine</title><idno type="eISSN">1530-0293</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenergic alpha-2 Receptor Agonists (therapeutic use)</term><term>Animals</term><term>Arterial Pressure (drug effects)</term><term>Clonidine (therapeutic use)</term><term>Dexmedetomidine (therapeutic use)</term><term>Hypotension (drug therapy)</term><term>Hypotension (etiology)</term><term>Hypotension (physiopathology)</term><term>Lipopolysaccharides</term><term>Male</term><term>Norepinephrine (therapeutic use)</term><term>Pilot Projects</term><term>Random Allocation</term><term>Rats</term><term>Rats, Sprague-Dawley</term><term>Shock, Septic (chemically induced)</term><term>Shock, Septic (complications)</term><term>Shock, Septic (physiopathology)</term><term>Vasoconstrictor Agents (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agonistes des récepteurs alpha-2 adrénergiques (usage thérapeutique)</term><term>Animaux</term><term>Attribution aléatoire</term><term>Choc septique ()</term><term>Choc septique (physiopathologie)</term><term>Clonidine (usage thérapeutique)</term><term>Dexmédétomidine (usage thérapeutique)</term><term>Hypotension artérielle (physiopathologie)</term><term>Hypotension artérielle (traitement médicamenteux)</term><term>Hypotension artérielle (étiologie)</term><term>Lipopolysaccharides</term><term>Mâle</term><term>Norépinéphrine (usage thérapeutique)</term><term>Pression artérielle ()</term><term>Projets pilotes</term><term>Rat Sprague-Dawley</term><term>Rats</term><term>Vasoconstricteurs (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic alpha-2 Receptor Agonists</term><term>Clonidine</term><term>Dexmedetomidine</term><term>Norepinephrine</term><term>Vasoconstrictor Agents</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Shock, Septic</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Shock, Septic</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Arterial Pressure</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hypotension</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hypotension</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Choc septique</term><term>Hypotension artérielle</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Hypotension</term><term>Shock, Septic</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Hypotension artérielle</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agonistes des récepteurs alpha-2 adrénergiques</term><term>Clonidine</term><term>Dexmédétomidine</term><term>Norépinéphrine</term><term>Vasoconstricteurs</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hypotension artérielle</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Lipopolysaccharides</term><term>Male</term><term>Pilot Projects</term><term>Random Allocation</term><term>Rats</term><term>Rats, Sprague-Dawley</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Attribution aléatoire</term><term>Choc septique</term><term>Lipopolysaccharides</term><term>Mâle</term><term>Pression artérielle</term><term>Projets pilotes</term><term>Rat Sprague-Dawley</term><term>Rats</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">During septic shock, vasopressors are a cornerstone of therapy. In septic shock, very high doses of vasopressors sometimes have to be used due to vascular desensitization, the mechanisms of which are poorly understood. This study assesses whether α-2 agonists increase pressor responsiveness following lipopolysaccharide administration.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001425 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001425 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:23963131
|texte= Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:23963131" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |